Gadducci A, Cosio S. Randomized Clinical Trials and Real World Prospective Observational Studies on
Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line
Treatment of Advanced Ovarian Carcinoma: A Critical Review. Anticancer Res 2021;41:4673-4685.
PMID: 34593415